Roche Holding AG (OTCQX International Premier:RHHBF)
| 346.15 Delayed Data As of Jun 02 |  +5.00 / +1.47%Today’s Change | 290.50 Today|||52-Week Range 432.00 | -11.13% Year-to-Date |
Latest RHHBF News | Press Releases
| Why Shares of Zentalis Pharmaceuticals Dropped This Week Jun 02 / MotleyFool.com - Paid Partner Content | Kodiak (KOD) Advances With Tarcocimab Amid Stiff Competition May 30 / Zacks.com - Paid Partner Content |
| Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk, Roche and Novartis Jun 01 / Zacks.com - Paid Partner Content | Sarepta (SRPT) Down 11% on FDA Extending DMD Gene Therapy Review May 25 / Zacks.com - Paid Partner Content |
| Sanofi (SNY) NextGen Multiple Sclerosis Drug Meets Phase II Goal May 31 / Zacks.com - Paid Partner Content | Alimera (ALIM) Completes Enrollment in Eye Disease Study May 25 / Zacks.com - Paid Partner Content |
| 5 Large Drug Stocks to Watch From a Thriving Industry May 31 / Zacks.com - Paid Partner Content | Why Shares of Rain Oncology Are Plummeting Today May 22 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 341.15 |
| Today’s open | 345.00 |
| Day’s range | 345.00 - 348.00 |
| Volume | 17 |
| Average volume (3 months) | 123 |
| Market cap | $36.9B |
Data as of 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -9.31% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -3.54% |
| P/E ratio | -- |
| Price/Sales | 4.68 |
| Price/Book | 9.13 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $66.3B |
| Annual profit (last year) | $13.0B |
| Net profit margin | 19.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
Chart unavailable
